Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
type: MedicalStudy
description: Phase II Randomized Study of Pemetrexed With Sorafenib Versus Pemetrexed Alone as Second-Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2007-09
end date: 2013-05
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00454194
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Alliance for Clinical Trials in Oncology
study subject: Lung Cancer
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Lung Cancer

AI Analytics
type: Organization